AC Immune ACIU
NASDAQ ACIU
$2.60 -0.01 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

AC Immune (ACIU) Enterprise Value (2016 - 2026)

Updated

AC Immune's Enterprise Value came in at $146.8 million for the quarter ended Jun 30, 2026, up 192.0% from $50.27 million a year earlier but down 20.3% from the prior quarter.

Analysis

AC Immune (ACIU) Enterprise Value (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, AC Immune reported Enterprise Value of -$198.68 million; for the year ended Dec 31, 2025, it was $209.22 million, up 152.1% from the prior year.

  • Enterprise Value carries a five-year compound annual growth rate of 9.8% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Enterprise Value was $83 million in the year ended Dec 31, 2024 (-75.2%), $334.61 million in the year ended Dec 31, 2023 (+695.2%), $42.08 million in the year ended Dec 31, 2022 (-78.6%) and $196.3 million in the year ended Dec 31, 2021 (+49.8%).
  • The five-year range for quarterly Enterprise Value is $25.81 million (the quarter ended Mar 31, 2025) to $379.37 million (the quarter ended Dec 31, 2021).
  • Year-over-year, Enterprise Value has increased for three consecutive quarters, with growth averaging 91.3% over the last eight quarters.
  • The fastest year-over-year change in Enterprise Value over five years came in the quarter ended Mar 31, 2026 (growth of 614.0%), and the weakest in the quarter ended Mar 31, 2025 (a decline of 85.1%).
  • Business Quant data shows ACIU's Enterprise Value at $184.28 million (quarter ended Mar 31, 2026), $205.1 million (quarter ended Dec 31, 2025) and $154.59 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AC Immune 265.55 Mn 265.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 146.80 Mn
Mar 31, 2026 184.28 Mn
Dec 31, 2025 205.10 Mn
Sep 30, 2025 154.59 Mn
Jun 30, 2025 50.27 Mn
Mar 31, 2025 25.81 Mn
Dec 31, 2024 82.20 Mn
Sep 30, 2024 192.72 Mn
Jun 30, 2024 202.15 Mn
Mar 31, 2024 173.53 Mn
Dec 31, 2023 332.59 Mn
Sep 30, 2023 147.83 Mn
Jun 30, 2023 143.24 Mn
Mar 31, 2023 81.68 Mn
Dec 31, 2022 111.85 Mn
Sep 30, 2022 118.31 Mn
Jun 30, 2022 141.31 Mn
Mar 31, 2022 145.69 Mn
Dec 31, 2021 379.37 Mn
Sep 30, 2021 277.30 Mn
API Access

AC Immune Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ACIU&period=max&api_key=YOUR_API_KEY